Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000250641 | SCV000320445 | uncertain significance | Cardiovascular phenotype | 2017-03-01 | criteria provided, single submitter | clinical testing | The p.R19949Q variant (also known as c.59846G>A), located in coding exon 154 of the TTN gene, results from a G to A substitution at nucleotide position 59846. The arginine at codon 19949 is replaced by glutamine, an amino acid with highly similar properties. This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this variant remains unclear. |
Eurofins Ntd Llc |
RCV000728537 | SCV000856127 | uncertain significance | not provided | 2017-07-28 | criteria provided, single submitter | clinical testing | |
Diagnostic Laboratory, |
RCV000728537 | SCV001741831 | uncertain significance | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics, |
RCV000728537 | SCV001922036 | uncertain significance | not provided | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000728537 | SCV001926587 | uncertain significance | not provided | no assertion criteria provided | clinical testing |